tenk.fyi

Coherus Oncology, Inc.

CHRSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$42.2M

59.8% YoY

Net Income

$168.0M

489.4% YoY

EPS

$1.43

472.0% YoY

Cash

$88.9M

29.5% YoY

FY 2025 · As of 2025-12-31